References – Understanding Cardiopulmonary Risk in COPD and Opportunities for New Treatment Modalities – EPR Issue 3 2024
- World Health Organisation. COPD Factsheet. Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Last accessed: May 2024.
- Donaldson GC, et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137:1091-1097;9-2029.
- Whittaker H, et al. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis. 2022;17:427-437.
- Rothnie KJ, et al. Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care Med. 2018;198(4): pp.464-471.
- HO TW, et al. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: A nationwide population-based study. PLOS ONE. 2014;9 (12): e114866.
- De Soyza A, et al. Large trials, new knowledge: the changing face of COPD management. Eur Respir J. 2015 Jun;45(6):1692-703. doi: 10.1183/09031936.00179714. Epub 2015 Mar 18. PMID: 25792640.
- American Lung Association. The Heart and Lungs: The Ultimate Relationship. Available at: https://www.lung.org/blog/heart-lung-relationship. Last accessed: May 2024.
- Chen, H. et al. Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above data from NHANES 2013–2018. BMC Pulm Med
- Act on COPD. Available at: https://www.actoncopd.com/hcp/evidence-base.html#:~:text=The%20lungs%20and%20the%20heart%20are%20fundamentally%20linked%20and%20work%20together.&text=COPD%20mechanisms%20elevate%20the%20risk,is%20termed%20%E2%80%9Ccardiopulmonary%20risk.%E2%80%9D. Last accessed: May 2024
- Klaus F. Rabe et al. Cardiovascular disease and COPD: dangerous liaisons? European Respiratory Review 2018 27: 180057; DOI: 10.1183/16000617.0057-2018
- Hurst et al. MACE in COPD: addressing cardiopulmonary risk. The Lancet, Volume 12, Issue 5, P345-348. Mar 2024
- Papaporfyriou A, et al. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy. Life (Basel). 2023 May 31;13(6):1299.
- Don D. Sin et al. Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases? Circulation, https://doi.org/10.1161/01.CIR.0000056767.69054.B3. Available at: https://www.ahajournals.org/doi/10.1161/01.CIR.0000056767.69054.B3#:~:text=Chronic%20obstructive%20pulmonary%20disease%20(COPD)%20is%20an,important%20risk%20factor%20for%20atherosclerosis.&text=Even%20modest%20reductions%20in%20expiratory,independent%20of%20other%20risk%20factors. Last accessed: May 2024
- The Parliament Magazine EU must act against ‘third biggest killer worldwide’ Available at: EU must act against ‘third biggest killer worldwide’ (theparliamentmagazine.eu). Last accessed: May 2024.
- Asthma + Lung UK, COPD in the UK Report. Available at: https://www.asthmaandlung.org.uk/sites/default/files/2023-03/delayed-diagnosis-unequal-care.pdf. Last accessed: May 2024.
- Eurostat data for 2011-2018, Causes of death – standardised death rate by region of residence. Available at: https://ec.europa.eu/eurostat/databrowser/view/HLTH_CD_ASDR2__custom_2053067/default/table?lang=en. Last accessed: May 2024
- Snell N, et al. S32 Epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British Lung Foundation’s ‘Respiratory health of the nation’ project, Thorax 2016;71:A20.
- Lindenauer PK, et al. Risk Trajectories of Readmission and Death in the First Year After Hospitalization for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 Apr 15;197(8):1009-1017.
- García-Sanz MT, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017; 9 (3): 636‐ doi:10.21037/jtd.2017.03.34.
- Mannino DM, et al. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100: pp.115-122.
- NHS England. Respiratory Disease. Available at: https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/#:~:text=The%20annual%20economic%20burden%20of,the%20UK%20%C2%A311billion%20annually. Last accessed: May 2024
- Financial Times, COPD: A Public Health Priority. Available at: https://copd.live.ft.com/#:~:text=Chronic%20obstructive%20pulmonary%20disease%20(COPD,both%20the%20public%20and%20policymakers. Last accessed: May 2024
- Salciccioli JD, et al. Respiratory disease mortality in the United Kingdom compared with EU15+ countries in 1985-2015: observational study. BMJ. 2018 Nov 28;363:k4680. doi: 10.1136/bmj.k4680. PMID: 30487157; PMCID: PMC6259045.
- Singh D, et al. Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals. Int J Chron Obstruct Pulmon Dis. 2021 Nov 1;16:3009-3016. doi: 10.2147/COPD.S329316. PMID: 34754186; PMCID: PMC8570921.
- Shrikrishna D, et al. Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease? Eur Heart J. 2024 Jan 27;45(4):247-249. doi: 10.1093/eurheartj/ehad669. PMID: 37832033; PMCID: PMC10821359.
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024. [Online]. Available at: https://goldcopd.org/2024-gold-report/. Last accessed: May 2024
- Singh, D. Et al. Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review. Adv Ther (2024). https://doi.org/10.1007/s12325-024-02855-4
- Campion E Quinn, 100 Questions & Answers about Chronic Obstructive Pulmonary Disease (COPD).
- Swart KMA, et al. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands. Respir Res. 2023 Nov 21;24(1):293. doi: 10.1186/s12931-023-02601-4.
- Kunisaki KM, et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
- Hawkins NM, et al. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease. Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487. PMID: 38182279; PMCID: PMC11103306.
- Daniels K, et al. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. Int J Chron Obstruct Pulmon Dis. 2024;19:225-241
- O’Toole J, et al. Understanding barriers to and strategies for medication adherence in COPD: a qualitative study. BMC Pulm Med. 2022 Mar 19;22(1):98. doi: 10.1186/s12890-022-01892-5. PMID: 35305609; PMCID: PMC8934480.
- Stolz D., et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. The Lancet Commissions. Vol.400 Issue 10356 (Sept. 2022); pp.921-972.